Humasis Co. Ltd. manufactures and sells pharmaceuticals and medical devices in South Korea and internationally. Its product range includes immunodiagnostic kits for quantitative and qualitative tests, cardiac and cancer markers, infectious diseases, hormones, and women's health. The company also offers bio-material products such as COVID-19 nucleocapsid protein, human immunodeficiency virus surface proteins, a COVID-19 RT-PCR kit, a COVID-19 Variant RT-qPCR kit, and an MPXV real-time PCR kit for the qualitative detection of nucleic acid from Monkeypox virus. In addition, it provides diagnostic equipment including urinalysis devices, blood glucose meters, and immunodiagnostic tools, as well as other test kits such as Cotinine for testing cotinine in urine and G6PD, an in vitro diagnostic test for detecting glucose-6-phosphate dehydrogenase in human whole blood. Founded in 2000, the company is headquartered in Anyang-si, South Korea.